To validate this finding in cancer cells, time-course treatments (2–16 h) of MDA-MB-468 cells with 5 μM tcyDTDO were performed, and the mRNA level of DR5 was measured by RT-PCR and quantitative PCR. This evidence concerns the gene TNFRSF10B and cancer.